A new UBCO study finds people are using small doses of psychedelics not for recreational purposes, but to combat anxiety and depression.
Psychedelics used to combat anxiety and depression, not to get high
An international study led by UBC Okanagan researchers suggests repeated use of small doses of psychedelics such as psilocybin or LSD can be a valuable tool for those struggling with anxiety and depression.
The study, recently published in Nature: Scientific Reports, demonstrated fewer symptoms of anxiety and depression, and greater feelings of wellbeing among individuals who reported consuming psychedelics in small quantities, or microdosing, compared to those who did not.
Microdosing involves regular self-administration of psychedelic substances in amounts small enough to not impair normal cognitive functioning.
Considering this is the largest psychedelic microdosing study published to date, the results are encouraging, says UBCO doctoral student and lead author Joseph Rootman.
“In total, we followed more than 8,500 people from 75 countries using an anonymous self-reporting system—about half were following a microdosing regimen and half were not,” Rootman explains. “In comparing microdosers and non-microdosers, there was a clear association between microdosing and fewer symptoms of depression, anxiety and stress—which is important given the high prevalence of these conditions and the substantial suffering they cause.”
The study is also the first to systematically examine the practice of stacking, or combining microdoses of psychedelics with other substances like niacin, lions mane mushrooms and cacao, which some believe work in conjunction to maximize benefit.
Rootman works with Dr. Zach Walsh, a psychology professor in UBCO’s Irving K. Barber Faculty of Arts and Social Sciences. Dr. Walsh says it’s an exciting time for research in this area.
“These findings highlight adults who are microdosing to treat their mental health conditions and enhance their wellbeing—rather than simply to get high,” says Dr. Walsh. “We have an epidemic of mental health problems, with existing treatments that don’t work for everyone. We need to follow the lead of patients who are taking these initiatives to improve their wellbeing and reduce suffering.”
Study co-author Kalin Harvey is the chief technology officer of Quantified Citizen, a mobile health research platform. He says this study highlights the potential of citizen science.
“The use of citizen science allows us to examine the effects of behaviours that are difficult to study in the lab due to regulatory challenges and stigma associated with the now discredited ‘war on drugs.’”
According to the Canadian Mental Health Association, one in five Canadians personally experience a mental health problem or illness each year. This is one of the many reasons Dr. Walsh says conducting innovative psychological research is imperative.
“These cross-sectional findings are promising and highlight the need for further investigation to better determine the impacts of factors like dosage and stacking,” explains Dr. Walsh.
“While the data is growing to support the use of psychedelics like psilocybin in large doses to treat depression and addiction—our data also helps to expand our understanding of how psychedelics may also help in smaller doses.”
Original Article: UBCO study finds psychedelic microdosing improves mental health
More from: University of British Columbia
The Latest on: Microdoses of psychedelics
- Canadian Senator Admits He Takes Psilocybin For Depressionon May 23, 2022 at 11:38 am
Last week, Canadian Senator Larry Campbell came out of the psychedelic closet in the opening ... admitted she had been spiking his coffee with microdoses of psilocybin. The admission is ...
- Psychedelics As Treatment Options For Mental Healthon May 19, 2022 at 6:28 am
"More and more studies reveal that regulated doses of psychedelics like LSD, psilocybin (magic mushrooms), MDMA, or ketamine in controlled settings could be viable treatments for a laundry list of ...
- How psychedelic treatments are helping people with mental illnesson May 17, 2022 at 12:10 pm
In most cases, these are Schedule I substances, like MDMA and psilocybin, that the government has labeled as drugs with a high risk for abuse no current accepted medical use, but recent research has ...
- How To Microdose LSD In 5 Easy Stepson May 8, 2022 at 8:12 pm
Psychedelic Spotlight does not condone the ... Any difficulties you had Do this for a week before you start taking LSD microdoses, and throughout the entire time that you are microdosing.
- TechCrunch+ roundup: Psychedelic investor survey, 6 issues VCs look for, hiring on a budgeton May 6, 2022 at 1:05 pm
For years, consumers have used substances like cannabis and microdoses of LSD and psilocybin ... more about the applications attracting VCs to psychedelics, reporter Anna Heim interviewed five ...
- The World's Largest Microdosing Clinical Trial Has Been Completed, Here Are The Resultson May 4, 2022 at 10:20 am
however in much smaller ‘microdoses’, the medicine is sub-perceptual.” That means that patients could benefit from LSD without experiencing the psychedelic effects. However, an earlier and ...
- Professors Charles Nichols, PhD and Peter Hendricks, PhD appointed co-Editors-in-Chief of Psychedelic Medicineon April 28, 2022 at 5:00 pm
and low doses or “microdoses” of psilocybin in the treatment of demoralization. Dr. Hendricks is also site PI of a NIDA-funded study of psilocybin for smoking cessation. “Psychedelic ...
via Bing News
The Latest on: Microdoses of psychedelics
via Google News